Noxafil (posaconazole) oral suspension — Highmark
Treatment of oropharyngeal candidiasis (thrush)
Preferred products
- generic fluconazole
- generic posaconazole oral suspension
Initial criteria
- Member is age ≥ 13 years
- Diagnosis of oropharyngeal candidiasis (thrush)
- Member has experienced therapeutic failure or intolerance to generic fluconazole
- If brand Noxafil oral suspension requested, member has experienced therapeutic failure or intolerance to generic posaconazole oral suspension
Reauthorization criteria
- Prescriber attests that the member has experienced positive clinical response to therapy
Approval duration
12 months